← Back to headlines
Stock Analysis: Cantor Fitzgerald Downgrades ADMA Biologics (ADMA)
Cantor Fitzgerald has downgraded ADMA Biologics (ADMA) to a Neutral rating, with reasons provided for the change in their investment stance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
IMF Chief Warns Global Economy Faces Energy Shocks and Fiscal Pressures
15m ago
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
30m ago
TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
35m ago
Montenegro Official Rejects Alleged Political Pressure Attempts
37m ago